跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
奥佛林 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Flucloxacillin Sodium Capsules
Approved
化学药品
Flucloxacillin Sodium Capsules
澳美製藥廠有限公司
🇨🇳 National Medical Products Administration
Approval Date
Jun 24, 2021
Approval ID
8BYsA1Q8v4B
Company
澳美製藥廠有限公司
Type
化学药品
Approval Details
Approval Id
8BYsA1Q8v4B
Approval Number
国药准字HC20160023
Generic Name
氟氯西林钠胶囊
Generic Name En
Flucloxacillin Sodium Capsules
Trade Name
奥佛林
Brand Name
奥佛林
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
0.25g(按C19H17ClFN3O5S计)
Reg Date
2021-06-24
Expired Date
2026-06-23
Company Name
澳美製藥廠有限公司
Production Company Name
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Company Detail Path
/organization/ao-mei-zhi-yao-chang-you-xian-gong-si
Production Company Detail Path
/organization/bright-future-pharmaceutical-laboratories-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 24, 2021
Approval ID
8BYsA1Q8v4B
Type
化学药品
Back to NMPA Approvals